Evidence map›Paper›PMID 28418405›Full record

ArticleTranslational psychiatry2017

Adenosine A

A Oliveros, C H Cho, A Cui, S Choi, D Lindberg, D Hinton, M-H Jang, D-S Choi

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Blockade of adenosine AAlzheimer's research & therapy · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Adenosine AFrontiers in molecular neuroscience · 2018
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A OliverosDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.
C H ChoDepartment of Neurologic Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
A CuiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.
S ChoiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.
D LindbergNeurobiology of Disease Program, Mayo Clinic College of Medicine, Rochester, MN, USA.
D HintonNeurobiology of Disease Program, Mayo Clinic College of Medicine, Rochester, MN, USA.
M-H JangDepartment of Neurologic Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
D-S ChoiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.
Mayo Clinic · US

Funding

Alcohol and Adenosine-Mediated Glutamate Signaling in Neuro-Glial InteractionR01AA018779 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2019
$3.8M
NIAAA NIH HHS R01 AA018779
6 · The paper itself

Abstract

Dampened adenosine A

Indexed as

AnimalsCell ProliferationChoice BehaviorConditioning, ClassicalDoublecortin ProteinHippocampusImpulsive BehaviorMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, Inbred StrainsNeurogenesisPhosphorylationReaction TimeReceptors, Adenosine A2RewardDcx protein, mouseDoublecortin ProteinReceptors, Adenosine A2

Identifiers

PMID28418405
PMCPMC5416704
OpenAlexW2605558344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.